News

Video

A Patient's Self-Advocacy Leads to an Essential Thrombocythemia Diagnosis in Her 30s

Fact checked by:

While in nursing school, a patient recognized potential signs of a blood disorder and advocated for further testing, leading to an early diagnosis of essential thrombocythemia.

Despite initial dismissal of her concerns, a patient's persistent advocacy for her own health led to a diagnosis of essential thrombocythemia in her 30s.

Essential thrombocythemia is a type of myeloproliferative neoplasm (MPN) during which there is an overproduction of platelets.

Joy Ann Anderson, a patient with essential thrombocythemia for the past 24 years, was one of the seven MPN Heroes honored at an in-person event in December 2024. Anderson was nominated by someone who saw how much she puts towards supporting other patients with MPNs. She has provided one-on-one support over the last three years as an Imerman Angel and serves as a liaison for the MPN Research Foundation.

CURE spoke with Anderson before the event to talk about her initial diagnosis of essential thrombocythemia and the symptoms she experienced.

Transcript:

Yes, I had symptoms. I had severe headaches, and I was super fatigued. And I was only in my 30s, and I was, you know, trying to work full time and support my family. And I had kids, and it was really hard.

My PCP [primary care physician] said, “There's no way that you have this.” I was in nursing school, and I said, “I think I have essential thrombocythemia. My platelets have been super high. Here's my lab work.” And my PCP just really — I really had the push to see a hematologist oncologist.

So I finally got the order to see a hematologist oncologist, and he did a bone marrow biopsy right then and there, right in the office. And he said, “OK, we'll see, you know, if this is true.”

And six weeks later, I came back, and he said, “You were right. You have essential thrombocythemia. It's very rare for your age, but it, you know — you can just take a baby chemo pill, hydroxyurea, and come see me every six months, and, you know, normal … bloodwork and you'll be fine.”

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Bald Doctor.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.
Dr. Ritu Salani, the Director of Gynecologic Oncology at the University of California, Los Angeles (UCLA), UCLA Health, and a board-certified gynecologic oncologist.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
Image of Dr. Braun.
Dr. Sattva S. Neelapu is a professor and deputy department chair in the Department of Lymphoma/Myeloma, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, in Houston, as well as a member of Graduate Faculty, Immunology Program, Graduate School of Biomedical Sciences, at The University of Texas Health Science Center, also located in Houston.
Dr. Azka Ali is a medical oncologist at the Cleveland Clinic Taussig Cancer Institute, in Ohio.
Dr. Michael Bogenschutz
Photo credit: Max Mumby/Indigo via Getty Images